Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy
Abstract Platinum-based neoadjuvant chemotherapy prior to radical cystectomy is the preferred treatment for muscle-invasive bladder cancer despite modest survival benefit and significant associated toxicities. Here, we profile the global proteome of muscle-invasive bladder cancers pre- and post-neoa...
Saved in:
Main Authors: | A. Contreras-Sanz, G. L. Negri, M. J. Reike, H. Z. Oo, J. M. Scurll, S. E. Spencer, K. Nielsen, K. Ikeda, G. Wang, C. L. Jackson, S. Gupta, M. E. Roberts, D. M. Berman, R. Seiler, G. B. Morin, P. C. Black |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-55665-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Histopathology and proteomics are synergistic for high-grade serous ovarian cancer platinum response prediction
by: Oz Kilim, et al.
Published: (2025-01-01) -
Systemic Proteomic Analysis Reveals Distinct Exosomal Protein Profiles in Rheumatoid Arthritis
by: Qiu Qin, et al.
Published: (2021-01-01) -
Distinctive blood and salivary proteomics signatures in Qatari individuals at high risk for cardiovascular disease
by: Ghada Yousif, et al.
Published: (2025-02-01) -
The development of platinum-based alloys and their thermodynamic database
by: Cornish L.A., et al.
Published: (2002-01-01) -
Proteomic and Metabolomic Characterization of Metabolically Healthy Obesity: A Descriptive Study from a Swedish Cohort
by: J. Korduner, et al.
Published: (2021-01-01)